Tilray Brands Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 3,595

Employees

  • Stock Symbol
  • TLRY

Stock Symbol

  • Investments
  • 35

  • Share Price
  • $1.89
  • (As of Friday Closing)

Tilray Brands General Information

Description

Tilray is a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.

Contact Information

Website
www.tilray.com
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 265 Talbot Street West
  • Leamington, Ontario N8H 5L4
  • Canada
+1 (844)
Primary Industry
Pharmaceuticals
Other Industries
Distributors/Wholesale
Stock Exchange
NAS
Corporate Office
  • 265 Talbot Street West
  • Leamington, Ontario N8H 5L4
  • Canada
+1 (844)

Tilray Brands Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tilray Brands Stock Performance

As of 20-Nov-2026, Tilray Brands’s stock price is $1.89. Its current market cap is $279M with 148M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.89 $2.07 $1.87 - $15.70 $279M 148M 4.35M -$1.40

Tilray Brands Financials Summary

As of 31-Aug-2026, Tilray Brands has a trailing 12-month revenue of $963M.

In Thousands,
USD
TTM 31-Aug-2026 FY 2026 31-May-2026 FY 2025 31-May-2025 FY 2024 31-May-2024
EV 776,415 723,208 500,300 1,726,459
Revenue 963,100 915,454 821,309 788,942
EBITDA (31,469) 3,204 (2,138,931) (85,674)
Net Income (164,216) (121,397) (2,186,738) (244,981)
Total Assets 2,327,954 2,328,012 2,074,327 4,221,665
Total Debt 371,927 398,401 328,735 387,317
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tilray Brands Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tilray Brands‘s full profile, request access.

Request a free trial

Tilray Brands Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Tilray is a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives throug
Pharmaceuticals
Leamington, Canada
3,595 As of 2026

Smiths Falls, Canada
 

Stamford, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tilray Brands Competitors (3)

One of Tilray Brands’s 3 competitors is Canopy Growth, a Formerly Accelerator/Incubator backed company based in Smiths Falls, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Canopy Growth Formerly Accelerator/Incubator backed Smiths Falls, Canada
Curaleaf Holdings Formerly PE-Backed Stamford, CT
Acreage Holdings Formerly PE-Backed New York, NY
You’re viewing 3 of 3 competitors. Get the full list »

Tilray Brands Patents

Tilray Brands Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3217137-A1 Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof Pending 29-Apr-2021
US-12029720-B2 Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof Active 29-Apr-2021
US-12708633-B2 Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof Active 29-Apr-2021
US-20220347152-A1 Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof Active 29-Apr-2021
US-20240342130-A1 Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof Active 29-Apr-2021 A61K31/658
To view Tilray Brands’s complete patent history, request access »

Tilray Brands Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tilray Brands Investments & Acquisitions (35)

Tilray Brands’s most recent deal was a Merger/Acquisition with HelloMD. The deal was made on 29-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
HelloMD 29-Jun-2026 Merger/Acquisition Other Healthcare Technology Systems
Lyphe 15-Apr-2026 Merger/Acquisition Hospitals/Inpatient Services
BrewDog 02-Mar-2026 Merger/Acquisition Beverages
Solana Life Group 10-Nov-2025 Joint Venture Pharmaceuticals
Breckenridge Brewery 03-Sep-2025 Merger/Acquisition Beverages
You’re viewing 5 of 35 investments and acquisitions. Get the full list »

Tilray Brands ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

40.93 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Tilray Brands’s complete esg history, request access »

Tilray Brands Exits (5)

Tilray Brands’s most recent exit was on 03-Aug-2023 from Truss Beverages. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Truss Beverages 03-Aug-2023 Completed
MedMen Enterprises, USA 18-Sep-2021 Completed
Decibel Cannabis Company 28-Dec-2018 Completed
  • 3 buyers
Rose Lifescience 30-Nov-2018 Completed
  • 2 buyers
Nualtis 08-May-2018 PIPE Completed
To view Tilray Brands’s complete exits history, request access »

Tilray Brands Affiliates

Subsidiaries (16)

Name Industry Location Year Founded
Smith & Sinclair Weesp, Netherlands 2014
Tilray Medical Italia Vado Ligure, Italy 2013
HelloMD Larkspur, CA 2013
Montauk Brewing Company Montauk, NY 2012
Hop Valley Brewing Company Eugene, OR 2009
You’re viewing 5 of 16 affiliates. Get the full list.  »

Tilray Brands FAQs

  • When was Tilray Brands founded?

    Tilray Brands was founded in 2013.

  • Where is Tilray Brands headquartered?

    Tilray Brands is headquartered in Leamington, Canada.

  • What is the size of Tilray Brands?

    Tilray Brands has 3,595 total employees.

  • What industry is Tilray Brands in?

    Tilray Brands’s primary industry is Pharmaceuticals.

  • Is Tilray Brands a private or public company?

    Tilray Brands is a Public company.

  • What is Tilray Brands’s stock symbol?

    The ticker symbol for Tilray Brands is TLRY.

  • What is the current stock price of Tilray Brands?

    As of 20-Nov-2026 the stock price of Tilray Brands is $1.89.

  • What is the current market cap of Tilray Brands?

    The current market capitalization of Tilray Brands is $279M.

  • What is Tilray Brands’s current revenue?

    The trailing twelve month revenue for Tilray Brands is $963M.

  • Who are Tilray Brands’s competitors?

    Canopy Growth, Curaleaf Holdings, and Acreage Holdings are competitors of Tilray Brands.

  • What is Tilray Brands’s annual earnings per share (EPS)?

    Tilray Brands’s EPS for 12 months was -$1.40.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process